Overview of Nosocomial Infections Caused by Gram-Negative Bacilli
The DOI matches its Crossref record; 23 of the 26 references it cites were found in a registry or an index.
Abstract
We analyzed data from the National Nosocomial Infections Surveillance (NNIS) System from 1986-2003 to determine the epidemiology of gram-negative bacilli in intensive care units (ICUs) for the most frequent types of hospital-acquired infection: pneumonia, surgical site infection (SSI), urinary tract infection (UTI), and bloodstream infection (BSI). We analyzed >410,000 bacterial isolates associated with hospital-acquired infections in ICUs during 1986-2003. In 2003, gram-negative bacilli were associated with 23.8% of BSIs, 65.2% of pneumonia episodes, 33.8% of SSIs, and 71.1% of UTIs. The percentage of BSIs associated with gram-negative bacilli decreased from 33.2% in 1986 to 23.8% in 2003. The percentage of SSIs associated with gram-negative bacilli decreased from 56.5% in 1986 to 33.8% in 2003. The percentages pneumonia episodes and UTIs associated with gram-negative bacilli remained constant during the study period. The proportion of ICU pneumonia episodes associated with Acinetobacter species increased from 4% in 1986 to 7.0% in 2003 (P<.001, by the Cochran-Armitage chi2 test for trend). Significant increases in resistance rates were uniformly seen for selected antimicrobial-pathogen combinations. Gram-negative bacilli are commonly associated with hospital-acquired infections in ICUs. The proportion of Acinetobacter species associated with ICU pneumonia increased from 4% in 1986 to 7.0% in 2003.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As a group, these organisms are the most common etiology of nosocomial infections, including most cases of hospital-acquired pneumonia, ventilator-associated pneumonia and healthcare-associated pneumonia, and they are important causes of morbidity and death in hospitalized patients (1).”
From Hepcidin-mediated iron sequestration protects against bacterial dissemination during pneumonia (2017) · cites this paper as [1]
Citations
Cites
Vincent, J.-L. (1995) · JAMA · doi:10.1001/jama.1995.03530080055041 · Cited by 1,632 · cited 1×
“A recent review by Archibald [9] showed that the types of pathogens encountered in health care institutions in North America, Europe, Asia, Australia, and even Africa are, for the most part, similar [10-14].”
Hospital Epidemiology and Infection Control
Mayhall, C. G. (2011) · Cited by 1,179
National nosocomial infections surveillance system (NNIS): Description of surveillance methods
Emori, T. G., Culver, D. H., Horan, T. C., Jarvis, W. R., White, J. W., Olson, D. R., Banerjee, S., Edwards, J. R., Martone, W. J., Gaynes, R. P., et al. (1991) · American Journal of Infection Control · doi:10.1016/0196-6553(91)90157-8 · Cited by 832
Self-citationSurveillance nosokomialer Infektionen
Gastmeier (2004) · Therapeutische Umschau · doi:10.1024/0040-5930.61.3.204 · Cited by 509
Epidemiology and control of nosocomial infections in adult intensive care units
Weinstein, R. A. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90366-6 · Cited by 300 · cited 1×
“the 4 most frequent types of hospital-acquired infection: pneumonia, surgical site infection (SSI), urinary tract infection (UTI), and bloodstream infection (BSI) [1].”
BackgroundSelf-citationMultidrug-Resistant Acinetobacter baumannii
Abbo, A., Navon-Venezia, S., Hammer-Muntz, O., Krichali, T., Siegman-Igra, Y., & Carmeli, Y. (2005) · Emerging Infectious Diseases · doi:10.3201/eid1101.040001 · Cited by 285 · cited 1×
“Acinetobacter organisms are intrinsically resistant to many antimicrobials and can acquire resistance to others [7].”
BackgroundHOSPITAL ACQUIRED INFECTIONS: KNOWLEDGE ABOUT IT AND ITS PREVENTION
QAYYUM, S., WAQAS, B., & SATTAR, A. (2010) · The Professional Medical Journal · doi:10.29309/tpmj/2010.17.02.2211 · Cited by 256
MAGNITUDE AND PREVENTION OF NOSOCOMIAL INFECTIONS IN THE INTENSIVE CARE UNIT
Fridkin, S. K., Welbel, S. F., & Weinstein, R. A. (1997) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(05)70366-4 · Cited by 225 · cited 1×
“A recent review by Archibald [9] showed that the types of pathogens encountered in health care institutions in North America, Europe, Asia, Australia, and even Africa are, for the most part, similar [10-14].”
BackgroundSelf-citationStreit, J. M., Jones, R. N., Sader, H. S., & Fritsche, T. R. (2004) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2003.12.019 · Cited by 191
Syncope and orthostatic hypotension
Atkins, D., Hanusa, B., Sefcik, T., & Kapoor, W. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90012-m · Cited by 172
Research works printed but not linked: 2
- 1991, The American journal of medicine, 91, 86
- Richards, 2003, Annals of surgery, 237, 358, 10.1097/00000658-200303000-00009 · doi:10.1097/00000658-200303000-00009
Cited by
Items 901–1,000 of 1,000
Acinetobacter Baumannii Native Valve Infective Endocarditis: A Case Report
Lahmidi, I., Darar, C., Elouafi, N., & Bazid, Z. (2020) · Cureus · doi:10.7759/cureus.11527 · Cited by 8
Drug Utilization Evaluation of Imipenem in an Educational Hospital in Mazandaran Province
Shiva, A., Salehifar, E., Amini, M., Ala, S., Rafati, M. R., & Ganji, R. (2014) · Pharmaceutical Sciences · Cited by 8
The Effect of Klebsiella pnemoniae on Catfish (Clarias gariepinus)
Ao, U., Nwanze, J. C., Onoh, C. C., & Okonko, I. O. (2012) · Cited by 8
Risk factors for carbapenem-nonsusceptible Pseudomonas aeruginosa : Case–control study
Khadem, T. M., Stevens, V. W., Holt, K. D., Hoffmann, C., Dumyati, G. K., & Brown, J. E. (2017) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2017.06.017 · Cited by 8
Pecan shell by-products—phenolic compound contents and antimicrobial properties
Huang, C. Y., Riskowski, G. L., Chang, J., Lai, J. T., & Chang, A. C. (2020) · DOAJ (DOAJ: Directory of Open Access Journals) · doi:10.3934/agrfood.2020.2.218 · Cited by 8
Chotimakorn, P., Pattharachayakul, S., Lertsrisatit, Y., Santimaleeworagun, W., Tansakul, P., Yingkajorn, M., Chelae, S., Pomwised, R., Chukamnerd, A., Soontarach, R., et al. (2025) · Antibiotics · doi:10.3390/antibiotics14030322 · Cited by 7
Altura, B. M. (2016) · International Journal of Vaccines and Research · doi:10.19070/2572-7427-160003e · Cited by 7
“In the past few years, many hospitalized patients have died of common and once treatable bacterial diseases, such as pneumonia, and blood (septic) or urinary tract infections [1-8].”
BackgroundInfluentialKian, B., Mirnejad, R., Moradli, G., Mirkalantari, S., & Golmohammadi, R. (2018) · Iranian journal of pathology · doi:10.30699/ijp.13.2.144 · Cited by 7
“, and Acinetobacter baumannii, cause nosocomial infections with different dissemination patterns in the countries (2,4).”
BackgroundLi, Q., Liu, B., & Liu, L. (2021) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.13446 · Cited by 7
Zaky, A. F., Zeliadt, S. B., & Treggiari, M. M. (2015) · Anaesthesia and Intensive Care · doi:10.1177/0310057x1504300105 · Cited by 8
“The studies by de Smet (1), de Smet (2) and Melsen compared two intervention groups for selective digestive decontamination and selective oral decontamination.”
BackgroundInfluentialAntimicrobial Resistance and Clones ofAcinetobacterSpecies andPseudomonas aeruginosa
Lee, J., & Ko, K. S. (2012) · Journal of Bacteriology and Virology · doi:10.4167/jbv.2012.42.1.1 · Cited by 7
“healthcare-associated pneumonia including ventilatorassociated pneumonia (8).”
Forecast of Antibiotic Development in an Era of Increasing Bacterial Resistance
Eiland, E. H., & Gatlin, D. (2008) · Journal of Pharmacy Practice · doi:10.1177/0897190008318499 · Cited by 9
Gupta, S., Kumar, M., Shergill, S. P. S., & Tandel, K. (2020) · African Journal of Laboratory Medicine · doi:10.4102/ajlm.v9i1.991 · Cited by 7
Liew, K. C., O’Keeffe, J. C., Rajandas, H., Lee, Y. P., Harris, O. M., Parimannan, S., Croft, L., & Athan, E. (2023) · Antibiotics · doi:10.3390/antibiotics12030483 · Cited by 8
Abbas, S. H., Khan, I. M. Z. U. I., Naeem, M., Adil, M., Naz, S. M., Khan, A., & Khan, M. U. (2015) · PubMed · Cited by 7
Characterization of imipenem resistance mechanisms in Pseudomonas aeruginosa isolates from Turkey
Aogáin, M. M., Külah, C., Rijnsburger, M. C., Çelebi, G., Savelkoul, P. H. M., O’Gara, F., & Mooij, M. J. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03899.x · Cited by 7
“Pseudomonas aeruginosa is a major cause of nosocomial infections and is associated with hospital-acquired pneumonia as well as urinary tract, surgical site and bloodstream infections [1,2].”
BackgroundSekhri, K., Nandha, R., Mandal, A., Bhasin, D., & Singh, H. (2013) · Indian Journal of Pharmacology · doi:10.4103/0253-7613.121373 · Cited by 7
Risk Factors for Efflux Pump Overexpression in Fluoroquinolone-Resistant Escherichia coli
Han, J., Nachamkin, I., Tolomeo, P., Mao, X., Bilker, W. B., & Lautenbach, E. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis567 · Cited by 7
Sherchan, J. B., Gurung, P., Bam, D. S., & Sherchand, J. B. (2013) · Nepal Journal of Science and Technology · doi:10.3126/njst.v13i1.7454 · Cited by 7
Bhanu, L. S. M., Nishimura, S., & Aparna, H. S. (2016) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2016.03.049 · Cited by 7
Prognostic differences between VAP from Acinetobacter baumanii and VAP from other microorganisms.
Bonito, M. D., Caiazzo, S., Iannazzone, M., Miccichè, V., Marco, G. D., ROBERTIS, E. D., Tufano, R., & Piazza, O. (2012) · PubMed Central · Cited by 7
The burden of central line-associated bloodstream infections in children with medical complexity
Scarselli, A., Smarrazzo, A., Sanctis, F. D., Ravà, L., Carletti, M., Atti, M. L. C. D., Aversa, M., Drago, R., Crocoli, A., Geremia, C., et al. (2021) · The Journal of Vascular Access · doi:10.1177/11297298211027468 · Cited by 8
Mahto, M., Shah, A., Show, K. L., Moses, F., & Stewart, A. (2021) · Public Health Action · doi:10.5588/pha.21.0048 · Cited by 7
MRSA Prophylaxis in Spine Surgery Decreases Postoperative Infections
Conaway, W. K., Lambrechts, M. J., D’Antonio, N. D., Karamian, B. A., DiMaria, S. L., Mao, J. Z., Canseco, J. A., Rihn, J. A., Kurd, M. F., Woods, B. I., et al. (2022) · Clinical Spine Surgery A Spine Publication · doi:10.1097/bsd.0000000000001396 · Cited by 7
Impact of hyperglycemia on outcomes of patients with Pseudomonas aeruginosa bacteremia
Patel, T. S., Cottreau, J. M., Hirsch, E. B., & Tam, V. H. (2015) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2015.10.024 · Cited by 9
In Vitro Evaluation of Novel Compounds against Selected Resistant Pseudomonas aeruginosa Isolates
Housman, S. T., Sutherland, C. A., & Nicolau, D. P. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05944-11 · Cited by 7
Kamga, H., Nsagha, D., Assob, J., Njunda, A., & Tchape, G. (2012) · African Journal of Clinical and Experimental Microbiology · doi:10.4314/ajcem.v13i2.10 · Cited by 9
“Gaynes and Edwards [12] in their surveillance study on nosocomial infections caused by gram-negative bacteria in intensive care units from a study period of 1986 to 2003, found that gram negative bacteria caused 23.”
BackgroundInfluentialEarly appropriate therapy of Gram-positive bloodstream infections: the conservative use of new drugs
Grossi, P. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(09)70563-1 · Cited by 7
Kang, H., & Kim, S. (2012) · Korean Journal of Clinical Microbiology · doi:10.5145/kjcm.2012.15.1.21 · Cited by 7
Tokajian, S. T., Eisen, J. A., Jospin, G., Hamzé, M., Rafei, R., Salloum, T., Ibrahim, J., & Coil, D. A. (2016) · Genome Announcements · doi:10.1128/genomea.01678-15 · Cited by 7
Aryanezhad, M., Shakibaie, M. R., Karmostaji, A., & Shakibaie, S. (2016) · Infection Epidemiology and Medicine · doi:10.18869/modares.iem.2.4.1 · Cited by 7
“3% of these infections, respectively (3, 4).”
Jayaweera, J. A. A. S., & Reyes, M. (2019) · BMC Research Notes · doi:10.1186/s13104-019-4624-2 · Cited by 7
RetractedAllen, D. M., & Hartman, B. J. (2010) · Elsevier eBooks · doi:10.1016/b978-0-443-06839-3.00222-8 · Cited by 7
Review: Novel targets in the management of pneumonia
Diaz-Caballero, L. A., Mortensen, E. M., Anzueto, A., & Restrepo, M. I. (2008) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753465808098694 · Cited by 7
“An analysis of over 410,000 isolates from the National Nosocomial Infection Surveillance (NNIS) system reported that pneumonia due to S. aureus had more than doubled from 13.4% in 1975 to 27.8% in 2003 [Gaynes and Edwards, 2005].”
BackgroundInfluentialSuperbugs in ICU: is there any hope for solution?
Trivedi, T. H., & Sabnis, G. R. (2009) · PubMed · Cited by 7
Carvalho, M., de Carvalho, T. B., Barbosa, J. B., Teixeira, P., & Bergogne-Bérézin, E. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-822521-9.00212-4 · Cited by 7
Shome, A., Ali, S. A., Roy, D., Dey, S., Sinha, S., Barman, P., Kumar, A., Chakroborty, R., Haydar, M. S., Roy, S., et al. (2025) · Bioprocess and Biosystems Engineering · doi:10.1007/s00449-025-03149-x · Cited by 6
Swamy, S., & Sharma, R. (2015) · Infectious Diseases in Clinical Practice · doi:10.1097/ipc.0000000000000362 · Cited by 6
Hebl, J. R., & Horlocker, T. T. (2010) · Regional Anesthesia & Pain Medicine · doi:10.1097/aap.0b013e3181fa69fd · Cited by 6
“The microorganism represents a relatively common cause of nosocomial gram-negative bacillary infectionsVaccounting for 18% of hospital-based gram-negative bacteremias and 4% of all bacteremias within the United States.(3) Enterobacter aerogenes is also a gram-negative, rod-shaped bacterium that is commonly found withi…”
BackgroundAcyl Homoserine Lactone in Interspecies Bacterial Signaling
Kanojiya, P., Banerji, R., & Saroj, S. D. (2022) · Microbiology and Biotechnology Letters · doi:10.48022/mbl.2111.11012 · Cited by 7
Importance of Pseudomonas aeruginosa in Food Safety and Public Health
Tutun, S., & Yurdakul, Ö. (2023) · Turkish Journal of Agriculture - Food Science and Technology · doi:10.24925/turjaf.v11i10.2016-2026.6155 · Cited by 6
“P. aeruginosa is reported at a rate of 13.2–22.6% in intensive care units and is responsible for 11-13.8% of all nosocomial infections (Weinstein et al., 2005; Kim et al., 2000).”
BackgroundInfluentialThompson, E., Badu, A. T., Abban, E., Eyeson, E. B., Afutu, L. L., Amankwaah, B., Buabeng, S. D., Frimpong, A. A., Anning, A. S., & Ghartey‐Kwansah, G. (2024) · BMC Infectious Diseases · doi:10.1186/s12879-023-08894-6 · Cited by 7
“However, some studies reported P. aeruginosa to be more resistant to antibiotics instead [38, 39].”
ResultLu, H., Wang, C., Lu, W., Li, X., Wang, G., Dong, W., Wang, X., Chen, H., & Tan, C. (2024) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2024.107104 · Cited by 6
Abdominal wound closure in the presence of sepsis: our experience with the use of subcutaneous drain
Tagar, E., Kpolugbo, J., Dongo, A. E., Osime, C., Irekpita, E., & Irabor, D. (2024) · Ghana Medical Journal · doi:10.4314/gmj.v58i1.5 · Cited by 6
Cavallaro, A., Majewski, P. J., BARTON, M. D., & Vasilev, K. A. (2014) · Materials science forum · doi:10.4028/www.scientific.net/msf.783-786.1389 · Cited by 8
Immunological evaluation of OMP-F of native Iranian Pseudomonas aeruginosa as a protective vaccine
Ahmadi, H., Tabaraie, B., Maleknia, S., Pormirzagholi, F., Nejati, M., & ., M. H. H. (2012) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.2220 · Cited by 6
“Introduction Pseudomonas aeruginosa, a ubiquitous environmental Gram-negative microorganism, is a major cause of hospital-acquired infections [1,2].”
BackgroundRisk factors and outcomes of carbapenem-resistant Klebsiella pneumoniae infections
Pistella, E., & Santini, C. (2016) · Italian Journal of Medicine · doi:10.4081/itjm.2016.798 · Cited by 6
Volling, C., Thomas, S., Johnstone, J., Maltezou, H. C., Mertz, D., Stuart, R. L., Jamal, A. J., Kandel, C. E., Ahangari, N., Coleman, B. L., et al. (2020) · Journal of Hospital Infection · doi:10.1016/j.jhin.2020.08.024 · Cited by 6
Wang, C., Li, W., Gao, J., Zhang, D., Li, Y., Li, F., & Lei, J. (2020) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2020/8838447 · Cited by 6
“Studies from US hospitals reported that Gram-negative bacteria were more common in cases with ventilator-associated pneumonia and urinary tract infections [19] and Gram-negative bacteria were the dominant type of infection at the intensive care units [20].”
BackgroundBao, J., Ma, Y., Ding, M., Wang, C. C., Du, G., Zhou, Y., Guo, L., Kang, H., Wang, C., & Gu, B. (2021) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.23915 · Cited by 6
Malekzadegan, Y., Sadat, T. Z., Elham, R. M. N., Mohammad, T. S., Mohagheghzadeh, N., & Motamedifar, M. (2021) · Ethiopian Journal of Health Sciences · doi:10.4314/ejhs.v31i4.5 · Cited by 6
“A range of multidrug-resistant organisms, including Pseudomonas aeruginosa, Acinetobacter baumannii, and extendedspectrum β-lactamase (ESBL) and carbapenemase-producing Enterobacteriaceae are the cause of nosocomial infections (5).”
BackgroundAcinetobacter baumannii: Epidemiology, Clinical Manifestations and Associated Infections
Stanley, C., Awanye, A. M., & Ogbonnaya, U. C. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.1003618 · Cited by 14
Quorum Sensing in Acinetobacter baumannii
Bhargava, N., Sharma, P., & Capalash, N. (2014) · Springer eBooks · doi:10.1007/978-81-322-1982-8_10 · Cited by 6
“2011) with varying frequency of occurrence (Gaynes and Edwards 2005).”
Lu, S., Tsai, J., Tsao, T.-F., Liao, P.-F., & Sheu, J. (2015) · Paediatrics and International Child Health · doi:10.1080/20469047.2015.1109253 · Cited by 6
Queenan, A. M., Davies, T. A., He, W., & Lynch, A. S. (2013) · Journal of Chemotherapy · doi:10.1179/1973947813y.0000000074 · Cited by 6
Infections bronchopulmonaires à Stenotrophomonas maltophilia et à Acinetobacter baumannii
Baranzelli, A., Wallyn, F., & Nseir, S. (2013) · Revue de Pneumologie Clinique · doi:10.1016/j.pneumo.2013.02.005 · Cited by 6
Vanegas, J. M., Roncancio-Villamil, G., & Jiménez, J. N. (2014) · CES Medicina · Cited by 6
Curbing Resistance Development:Maximizing the Utility of Available Agents
Burgess, D. S. (2009) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2009.15.s5.5 · Cited by 6
Ghassemi, A., Farhangi, H., Badiee, Z., Banihashem, A., & Mosaddegh (2015) · PubMed Central · Cited by 6
Çöl, A., Dedeić-Ljubović, A., Salimović-Bešić, I., & Hukić, M. (2016) · Microbial Drug Resistance · doi:10.1089/mdr.2015.0257 · Cited by 6
Khazaei, S., Ayubi, E., Jenabi, E., Bashirian, S., Shojaeian, M., & Tapak, L. (2020) · Epidemiology and Health · doi:10.4178/epih.e2020037 · Cited by 6
Insect Ultra-Structures as Effective Physical-Based Bactericidal Surfaces
Romano, D., Bloemberg, J., McGloughlin, T. M., Dario, P., & Stefanini, C. (2020) · IEEE Transactions on Medical Robotics and Bionics · doi:10.1109/tmrb.2020.3000584 · Cited by 6
“associated pneumonia, surgical site infections, bloodstream infections, and urinary tract infections [5]–[7].”
BackgroundKim, C., Kassu, M., Smith, K. P., Kirby, J. E., & Manetsch, R. (2021) · ChemMedChem · doi:10.1002/cmdc.202100321 · Cited by 6
Bialvaei, A. Z., Razavi, S., Haghighat, F. N., Hemmati, A., Akhavan, M. M., Jeddi‐Tehrani, M., & Irajian, G. (2021) · Microbial Pathogenesis · doi:10.1016/j.micpath.2021.105060 · Cited by 6
Antibiotic Resistance in the Intensive Care Unit
Vilà, J., & Marco, F. (2007) · Springer eBooks · doi:10.1007/978-3-540-34406-3_19 · Cited by 6
Membrane proteomes of Pseudomonas aeruginosa and Acinetobacter baumannii
Dé, E., Cosette, P., Coquet, L., Siroy, A., Alexandre, S., Duncan, A. C., Naudin, B., Rihouey, C., Schaumann, A., Junter, G., et al. (2009) · Pathologie Biologie · doi:10.1016/j.patbio.2009.10.005 · Cited by 6
Host resistance to intranasalAcinetobacter baumanniireinfection in mice
Qiu, H., Li, Z., KuoLee, R., Harris, G., Gao, X., Yan, H., Xu, H. H., & Chen, W. (2016) · Pathogens and Disease · doi:10.1093/femspd/ftw048 · Cited by 6
Sabino, S. S. (2018) · doi:10.14393/ufu.di.2018.703 · Cited by 9
Leong, W., Lutz, C., Williams, J. G., Poh, Y., Yeo, B. K. Y., Chua, C., Rice, S. A., Givskov, M., Sanderson‐Smith, M. L., & McDougald, D. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.02.25.964320 · Cited by 6
“aeruginosa is an important pathogen, responsible for both acute 77 nosocomial infections (15) and chronic infections in leg ulcers and particularly in the lungs of 78 cystic fibrosis (CF) patients (16).”
BackgroundXiao, F., Cao, B., Wang, C., Guo, X., Li, M.-G., Xing, D., & Hu, X. (2020) · ACS Nano · doi:10.1021/acsnano.9b08805 · Cited by 6
RetractedBaraka, K., Abozahra, R., Khalaf, E. M., Bennaya, M. E., & Abdelhamid, S. M. (2025) · AIMS Microbiology · doi:10.3934/microbiol.2025007 · Cited by 5
“Multidrug-resistant P. aeruginosa is a serious health problem since it limits treatment options and lengthens hospital stays [40].”
Mustafa, U., Sarwar, Y., Mobeen, A., Khan, H. M. S., Abbas, W., Iftikhar, M., Zaheer, Y., Bukhari, S. Z., Hussain, D., An, R., et al. (2025) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2025.114880 · Cited by 5
Padmaja, N., Deborah Purushottam, M., & Srilalitha, V. (2025) · Bioinformation · doi:10.6026/973206300211475 · Cited by 5
Lizaso, D., Aguilera, K., Correa, M., Yantorno, M. L., Cuitiño, M., Expósito-Pérez, L., Lares, M., de la Parra, G., & Esposto, A. (2008) · Revista chilena de infectología · doi:10.4067/s0716-10182008000500010 · Cited by 5
Impact of total body weight on 30-day mortality in patients with gram-negative bacteremia
Hall, R. G., Yoo, E., Faust, A. C., Smith, T., Goodman, E. L., Mortensen, E. M., Richardson, S., & Álvarez, C. A. (2017) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2017.1328277 · Cited by 5
“It is noteworthy that the pathogens selected are the most common gram-negative bacteria responsible for bacteremia in this institution as well as previous literature [13,14].”
BackgroundCoron, N., Pavlíčková, S., Godefroy, A., Pailhories, H., Kempf, M., Cassisa, V., Marsollier, L., Marion, E., Joly‐Guillou, M., & Eveillard, M. (2017) · Future Microbiology · doi:10.2217/fmb-2016-0203 · Cited by 5
Lin, C., Wu, J., Huang, P., Sung, H., Tung, Y., Lai, C.-C., Wei, Y., & Fu, P. (2024) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2024.2324940 · Cited by 5
Dhurve, G., Behera, S. R., Gopinath, K., & Siddavattam, D. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.00817-24 · Cited by 5
Neou, E., Michail, G., Tsakris, A., & Pournaras, S. (2013) · Antibiotics · doi:10.3390/antibiotics2010073 · Cited by 5
Perianal Abscess and Proctitis byKlebsiella pneumoniae
Jeong, W. S., Choi, S. Y., Jeong, E. H., Bang, K. B., Park, S. S., Lee, D. S., Park, D. I., & Jung, Y. S. (2015) · Intestinal Research · doi:10.5217/ir.2015.13.1.85 · Cited by 5
Magill, D., Shaburova, O. V., Chesnokova, E., Pleteneva, E. A., Krylov, V. N., & Kulakov, L. A. (2015) · FEMS Microbiology Letters · doi:10.1093/femsle/fnv045 · Cited by 5
Efficacy of anti-pseudomonal antibiotics: need to reconsider the empirical use of cefepime.
Kotwal, A., Biswas, D., Kakati, B., Thakuria, B., & Bhardwaj, N. (2014) · PubMed Central · Cited by 6
Ranaei, M. A., Shahraki-Zahedan, S., Mohagheghi-Fard, A. H., Salimizand, H., Ordoni, R., & Amini, Y. (2020) · Gene Reports · doi:10.1016/j.genrep.2020.100626 · Cited by 5
Li, W., Li, Y., Yin, B., Lin, D., Sheng, H., & Zhang, N. (2021) · World Journal of Clinical Cases · doi:10.12998/wjcc.v9.i3.651 · Cited by 5
Ezeh, U. C., Achlatis, E., Crosby, T. W., Kwak, P. E., Phillips, M., & Amin, M. R. (2023) · The Laryngoscope · doi:10.1002/lary.30869 · Cited by 5
Souhail, B., Danjean, M., Mercier-Darty, M., Amaddeo, G., Sessa, A., Fihman, V., Galy, A., Woerther, P., & Lepeule, R. (2024) · BMC Infectious Diseases · doi:10.1186/s12879-023-08945-y · Cited by 5
“In Europe, ABC is typically involved in nosocomial infections in intensive care units, such as ventilated acquired pneumoniae and catheter-related infections [5, 6].”
BackgroundAlhhazmi, A. A., Alhazmi, R. A., Alahmadi, E. S., Almuallim, W. M., Aljurfi, Z. I., & Alturkostani, M. A. (2024) · Discovery Medicine · doi:10.24976/discov.med.202436183.80 · Cited by 5
RICAS, R. V., MARQUES, T. C., & Yamamoto, A. C. A. (2013) · Infarma - Ciências Farmacêuticas · doi:10.14450/2318-9312.v25.e4.a2013.pp178-181 · Cited by 5
“Todos estes fatores tornam-no responsável por uma morbidade e mortalidade elevada, especialmente, nos doentes críticos (7, 8).”
BackgroundDong, S.-X., Wang, J., & Chang, S. (2012) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2012.08.022 · Cited by 5
“Carbapenems have become one of the most important agents for treating infections caused by these multidrug resistance Gram-negative bacteria.(2) Doripenem was approved use in Taiwan in August 2009.”
BackgroundDawson, A., Trumper, P., Chrysostomou, G., & Hunter, W. N. (2013) · Acta Crystallographica Section F Structural Biology and Crystallization Communications · doi:10.1107/s174430911301292x · Cited by 5
Contact precautions in the intensive care unit setting: 12 years of surveillance
Piza, F. M. D. T., Marra, A. R., Silva, M., Camargo, T. Z. S., Figueiredo, R. A. D. O., & Edmond, M. B. (2012) · American Journal of Infection Control · doi:10.1016/j.ajic.2012.03.031 · Cited by 5
In Vitro Pharmacodynamics of AZD5206 against Staphylococcus aureus
Tam, V. H., Chang, K., Yang, Z., Newman, J., & Hu, M. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01208-12 · Cited by 5
“Staphylococcus aureus is a clinically important pathogen and a common cause of bloodstream, surgical site, skin, and skin structure infections, as well as nosocomial pneumonia (1).”
BackgroundAntibiotic Prophylaxis in Colorectal Surgery: Evolving Trends
Ongom, P. A. (2013) · Journal of Molecular Pharmaceutics & Organic Process Research · doi:10.4172/2329-9053.1000109 · Cited by 6
Polimixinas en la era de la multidrogorresistencia
Lorenzo, J. D. J. C., Ramírez, A. M., & Muñoz, Y. G. (2011) · Revista de enfermedades infecciosas en pediatría · Cited by 5
Clinical Issues of Resistance: Problematic Microbes: Enterobacteriaceae
Briceno, D. F., Torres, J. A., Soto, J. T., Quinn, J. P., & Villegas, M. V. (2011) · Springer eBooks · doi:10.1007/978-1-4614-1400-1_20 · Cited by 5
Chang, A. C., Huang, C. Y., Chang, J., Riskowski, G. L., Chan, W. K., & Lai, J. T. (2016) · Research Journal of Medicinal Plant · doi:10.3923/rjmp.2016.237.245 · Cited by 5
Antibiotic Use in the Mechanically Ventilated Patient
Niederman, M. S. (2008) · Elsevier eBooks · doi:10.1016/b978-0-7216-0186-1.50043-0 · Cited by 5
Hayashi, N., Furue, Y., Kai, D., Yamada, N., Yamamoto, H., Nakano, T., & Oda, M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0206696 · Cited by 5
Bacteria on the Soles of Patient-Issued Nonskid Slipper Socks: An Overlooked Pathogen Spread Threat?
Welle, M. K., Bliha, M., DeLuca, J., Frauhiger, A., & Lamichhane-Khadka, R. (2019) · Orthopaedic Nursing · doi:10.1097/nor.0000000000000516 · Cited by 5
Assessing the Efficacy of a Silver Carboxylate Antimicrobial Coating on Prosthetic Liners
Haglin, J. M., Garcia, D. R., Roque, D. L., Spake, C. S. L., Jarrell, J. D., & Born, C. T. (2019) · JPO Journal of Prosthetics and Orthotics · doi:10.1097/jpo.0000000000000271 · Cited by 5
Metadata
- Authors
- Weinstein, R. A., Gaynes, R., Edwards, J. R., & System, N. N. I. S.
- Affiliations
- Centers for Disease Control and Prevention (US)
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-09-15
- Volume
- 41
- Issue
- 6
- Pages
- 848-854
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2151958462
- Cited by
- 1,404
- References
- 26
- Citations by year
- 2026: 14 · 2025: 21 · 2024: 37 · 2023: 56 · 2022: 73 · 2021: 80 · 2020: 66 · 2019: 78 · 2018: 66 · 2017: 74 · 2016: 86 · 2015: 89 · 2014: 85 · 2013: 95 · 2012: 85
- FWCI
- 38.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Centers for Disease Control and Prevention
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Nosocomial Infections in ICU
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
- Keywords
- nosocomial infections, Gram-negative bacilli, intensive care unit, surgical site infection, urinary tract infection, bloodstream infection, Acinetobacter, antimicrobial resistance, epidemiological trends
- MeSH terms
- Cross Infection, Gram-Negative Bacteria, Humans, National Health Programs, Population Surveillance, Surgical Wound Infection, Time Factors, United States, Urinary Tract Infections, Gram-Negative Bacterial Infections, Pneumonia, Bacterial, Sepsis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.